For research use only, not for therapeutic use.
PHA-767491 hydrochloride(Cat No.:I005601)is a selective inhibitor of the protein kinase GSK-3 (glycogen synthase kinase 3), which is involved in numerous cellular processes, including glycogen metabolism, cell differentiation, and the regulation of signaling pathways related to cancer and neurodegenerative diseases. By inhibiting GSK-3, PHA-767491 hydrochloride can enhance Wnt signaling and promote neuroprotection, making it a candidate for therapeutic applications in conditions such as Alzheimer’s disease and various cancers. Ongoing research is focused on its pharmacological properties, safety profile, and potential clinical uses to leverage its beneficial effects in targeted therapies.
Catalog Number | I005601 |
CAS Number | 942425-68-5 |
Synonyms | PHA767491 hydrochloride; PHA-767491 hcl |
Molecular Formula | C12H11N3O.HCl |
Purity | ≥95% |
Target | Cdc7/CDK9 |
Solubility | DMSO: < 9 mg/mL |
Storage | 3 years -20C powder |
IC50 | 10 nM(Cdc7); 34 nM(Cdk9) Target: Cdc7/CDK9 |
IUPAC Name | 2-pyridin-4-yl-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one;hydrochloride |
InChI | InChI=1S/C12H11N3O.ClH/c16-12-9-7-11(8-1-4-13-5-2-8)15-10(9)3-6-14-12;/h1-2,4-5,7,15H,3,6H2,(H,14,16);1H |
InChIKey | IMVNFURYBZMFDZ-UHFFFAOYSA-N |
SMILES | C1CNC(=O)C2=C1NC(=C2)C3=CC=NC=C3.Cl |
Reference | <p> |